[1]
Balasubramanian, H.B., Biswas, S., Talmon, M., Patrucco, F., Balbo, P.E., Fresu, L.G. and Bagchi, A. 2024. Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis. Borneo Journal of Pharmacy. 7, 3 (Aug. 2024), 264–277. DOI:https://doi.org/10.33084/bjop.v7i3.7218.